BlackRock Fund Advisors - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 22 filers reported holding RECRO PHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q4 2016$151,000
-7.9%
18,677
+1.0%
0.00%
Q3 2016$164,000
+35.5%
18,499
+21.2%
0.00%
Q2 2016$121,000
+83.3%
15,268
+37.5%
0.00%
Q1 2016$66,000
-38.9%
11,105
-7.2%
0.00%
Q4 2015$108,000
-22.3%
11,971
+4.0%
0.00%
Q3 2015$139,000
+85.3%
11,515
+97.9%
0.00%
Q2 2015$75,0005,8200.00%
Other shareholders
RECRO PHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders